Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etomidate: an 'immunologically safe' anaesthetic agent.

J Watkins

    Anaesthesia
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Etomidate, an anesthetic, does not release histamine and may be safe for high-risk patients. Further research is needed to confirm its safety in cases involving muscle relaxants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for Double Beta Decays of ^{134}Xe with EXO-200 Phase II.

    Physical review letters·2026
    Same author

    Stable isotopes reveal an imprint of harmful algal blooms on Lake Erie.

    Aquatic ecosystem health & management·2026
    Same author

    Caribbean fish feces are an environmental hotspot of viable Symbiodiniaceae.

    Frontiers in microbiology·2026
    Same author

    Response to correspondence from McCarthy et al. regarding maternal sepsis screening and the role of the neutrophil-to-lymphocyte ratio.

    International journal of obstetric anesthesia·2025
    Same author

    Broadening of the Divertor Heat Flux Profile in High Confinement Tokamak Fusion Plasmas with Edge Pedestals Limited by Turbulence in DIII-D.

    Physical review letters·2024
    Same author

    Profile of and risk factors for early unplanned readmissions in patients with acute necrotizing pancreatitis.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2023
    Same journal

    Variation in peri-operative management of GLP-1 receptor agonists among UK anaesthetists.

    Anaesthesia·2026
    Same journal

    Management of major thoracic trauma: a narrative review.

    Anaesthesia·2026
    Same journal

    Pulmonary artery catheters or central venous catheters for cardiac surgery: the PUMA Pilot randomised clinical trial.

    Anaesthesia·2026
    Same journal

    Opioid-free vs. opioid-inclusive anaesthesia with or without regional anaesthesia for postoperative pain.

    Anaesthesia·2026
    Same journal

    Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention: a reply.

    Anaesthesia·2026
    Same journal

    Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention.

    Anaesthesia·2026
    See all related articles

    Area of Science:

    • Anesthesiology
    • Immunology

    Background:

    • Adverse anesthetic reactions involve complex immunological pathways.
    • Etomidate is distinguished by its lack of plasma histamine release.

    Purpose of the Study:

    • To review drug-induced disturbances in immunity related to anesthesia.
    • To investigate potential adverse reactions associated with etomidate use.

    Main Methods:

    • Review of immunological pathways in adverse anesthetic reactions.
    • Case analysis of patients experiencing reactions possibly linked to etomidate (1978-1982).
    • Investigation of specific cases involving etomidate, hypotension, and muscle relaxants (1982).

    Main Results:

    • Five cases (1978-1982) showed cutaneous flushing/urticaria, with two experiencing vomiting; etomidate's role was uncertain.

    Related Experiment Videos

  • Two cases in 1982 involved hypotension, likely due to concurrent use of suxamethonium/alcuronium.
  • Re-administration of etomidate with pancuronium was uneventful in one case; another remains unresolved, with muscle relaxants suspected.

    • Conclusions:

    • Etomidate's lack of severe reactions, especially cardiovascular effects, supports its use in high-risk patients.
    • Recommended for patients with allergies, atopy, or prior severe anaphylactoid responses.
    • Caution advised regarding potential interactions with specific muscle relaxants.